000 01304 a2200397 4500
005 20250512123640.0
264 0 _c19731212
008 197312s 0 0 eng d
024 7 _a10.1007/BF00421708
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLipsedge, M S
245 0 0 _aThe managment of severe agoraphobia: a comparison of iproniazid and systematic desensitization.
_h[electronic resource]
260 _bPsychopharmacologia
_cAug 1973
300 _a67-80 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
650 0 4 _aAdult
650 0 4 _aAnxiety
650 0 4 _aBehavior Therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIproniazid
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMethohexital
_xtherapeutic use
650 0 4 _aMonoamine Oxidase Inhibitors
_xtherapeutic use
650 0 4 _aPhobic Disorders
_xdrug therapy
650 0 4 _aPlacebos
650 0 4 _aProspective Studies
700 1 _aHajioff, J
700 1 _aHuggins, P
700 1 _aNapier, L
700 1 _aPearce, J
700 1 _aPike, D J
700 1 _aRich, M
773 0 _tPsychopharmacologia
_gvol. 32
_gno. 1
_gp. 67-80
856 4 0 _uhttps://doi.org/10.1007/BF00421708
_zAvailable from publisher's website
999 _c4746786
_d4746786